Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant

Mitsumasa Watanabe; Chishiho Nakamura; Sumie Fujii; Hitomi Kaneko; Hirokazu Hirata; Mitsuru Tsudo

doi:10.3109/10428194.2013.788698

Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant

Mitsumasa Watanabe, Chishiho Nakamura, Sumie Fujii, Hitomi Kaneko, Hirokazu Hirata, Mitsuru Tsudo

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2750-2752
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	54
Issue number	12
DOIs	https://doi.org/10.3109/10428194.2013.788698
Publication status	Published - 12-2013
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2013.788698

Cite this

@article{22d2389410404db5bd255b4a4fd0a70b,

title = "Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant",

author = "Mitsumasa Watanabe and Chishiho Nakamura and Sumie Fujii and Hitomi Kaneko and Hirokazu Hirata and Mitsuru Tsudo",

year = "2013",

month = dec,

doi = "10.3109/10428194.2013.788698",

language = "English",

volume = "54",

pages = "2750--2752",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "12",

}

Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant. / Watanabe, Mitsumasa; Nakamura, Chishiho; Fujii, Sumie et al.
In: Leukemia and Lymphoma, Vol. 54, No. 12, 12.2013, p. 2750-2752.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant

AU - Watanabe, Mitsumasa

AU - Nakamura, Chishiho

AU - Fujii, Sumie

AU - Kaneko, Hitomi

AU - Hirata, Hirokazu

AU - Tsudo, Mitsuru

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84887241013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887241013&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.788698

DO - 10.3109/10428194.2013.788698

M3 - Letter

C2 - 23517592

AN - SCOPUS:84887241013

SN - 1042-8194

VL - 54

SP - 2750

EP - 2752

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 12

ER -

Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this